High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$764K
$764,797
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
MLYS
S
Mineralys Therapeutics, Inc.
Karydas Daphne
• Director
10b5-1 SellΔOwn -32.6%
2026-03-31
$75,000
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -32.6%
|
2026-03-31 | $75,000 | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Karydas Daphne
• Director
Discretionary SellΔOwn -67.4%
2025-11-13
$689,797x2
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -67.4%
|
2025-11-13 | $689,797x2 | S | Form 4 |